Researchers receive £2.66M to test new immunotherapeutic strategy for non-small cell lung cancer

University of Liverpool researchers have secured £2.66m Medical Research Council funding to clinically test a novel immunotherapeutic strategy for non-small cell lung cancer – one of the most deadly cancers.

New USC study reveals how DNA loops silence gene activity

The blueprint for human life lies within the DNA in the nucleus of each of our cells. In human cells, around six and a half

January 17, 2024

Time-restricted eating shows promising weight and metabolic benefits, study reveals

A comprehensive meta-analysis of RCTs suggests meal timing strategies, such as time-restricted eating, offer moderate weight loss benefits and improved metabolic outcomes. However, evidence quality

November 12, 2024

Incannex Healthcare June 2023 Quarterly Activities Report and Appendix 4C Cash Flow Statement | Psychedelic Invest

Clinical stage pharmaceutical development company, Incannex Healthcare Limited (ASX: IHL / NASDAQ: IXHL), is pleased to provide its quarterly activities report and appendix 4C for

July 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.